Caspofungin

3 trials 2 recruiting JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

3 Sponsors

8 Countries

Phase III

Phase III: 3

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Basilea Pharmaceutica International AG Allschwil 1 Centre Hospitalier Universitaire Amiens Picardie 1

All trials

3 total

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A Phase 3 efficacy and safety study of fosmanogepix for the treatment of adult participants with candidemia and/or invasive candidiasis. Recruiting

2022-500455-23-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
Prospective multicenter randomized double-blind study comparing caspofungin to placebo for the treatment of ICU yeast intra-abdominal infect… Recruiting

2024-516266-11-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie

Showing 1–3 of 3 trials

← All drugs A–Z